Furnishings, Fixtures & Appliances
Compare Stocks
5 / 10Stock Comparison
IRBT vs SWK vs TTI vs NVCR vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Tools & Accessories
Oil & Gas Equipment & Services
Medical - Instruments & Supplies
Medical - Instruments & Supplies
IRBT vs SWK vs TTI vs NVCR vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Furnishings, Fixtures & Appliances | Manufacturing - Tools & Accessories | Oil & Gas Equipment & Services | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $2M | $12.47B | $1.32B | $1.92B | $161.07B |
| Revenue (TTM) | $547M | $15.23B | $630M | $674M | $10.58B |
| Net Income (TTM) | $-209M | $371M | $7M | $-173M | $2.98B |
| Gross Margin | 22.0% | 30.0% | 24.6% | 75.2% | 66.3% |
| Operating Margin | -29.5% | 7.8% | 8.4% | -27.2% | 30.5% |
| Forward P/E | — | 17.6x | 41.4x | — | 43.8x |
| Total Debt | $227M | $5.86B | $263M | $290M | $303M |
| Cash & Equiv. | $134M | $280M | $45M | $103M | $3.37B |
IRBT vs SWK vs TTI vs NVCR vs ISRG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Feb 26 | Return |
|---|---|---|---|
| iRobot Corporation (IRBT) | 100 | 0.1 | -99.9% |
| Stanley Black & Dec… (SWK) | 100 | 62.7 | -37.3% |
| TETRA Technologies,… (TTI) | 100 | 3454.5 | +3354.5% |
| NovoCure Limited (NVCR) | 100 | 18.4 | -81.6% |
| Intuitive Surgical,… (ISRG) | 100 | 260.8 | +160.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRBT vs SWK vs TTI vs NVCR vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRBT lags the leaders in this set but could rank higher in a more targeted comparison.
SWK is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 16 yrs, beta 1.83, yield 4.1%
- Lower P/E (17.6x vs 43.8x)
- 4.1% yield; 16-year raise streak; the other 4 pay no meaningful dividend
TTI ranks third and is worth considering specifically for momentum.
- +246.3% vs IRBT's -97.7%
Among these 5 stocks, NVCR doesn't own a clear edge in any measured category.
ISRG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.5% 10Y total return vs TTI's 96.4%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
- Beta 1.02, current ratio 4.87x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs IRBT's -23.4% | |
| Value | Lower P/E (17.6x vs 43.8x) | |
| Quality / Margins | 28.2% margin vs IRBT's -38.2% | |
| Stability / Safety | Beta 1.02 vs IRBT's 5.21, lower leverage | |
| Dividends | 4.1% yield; 16-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +246.3% vs IRBT's -97.7% | |
| Efficiency (ROA) | 14.8% ROA vs IRBT's -43.3%, ROIC 15.0% vs -38.6% |
IRBT vs SWK vs TTI vs NVCR vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IRBT vs SWK vs TTI vs NVCR vs ISRG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 2 of 6 categories
SWK leads 2 • TTI leads 1 • IRBT leads 0 • NVCR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SWK is the larger business by revenue, generating $15.2B annually — 27.8x IRBT's $547M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to IRBT's -38.2%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $547M | $15.2B | $630M | $674M | $10.6B |
| EBITDAEarnings before interest/tax | -$151M | $1.7B | $90M | -$165M | $3.8B |
| Net IncomeAfter-tax profit | -$209M | $371M | $7M | -$173M | $3.0B |
| Free Cash FlowCash after capex | -$107M | $726M | $3M | -$48M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +22.0% | +30.0% | +24.6% | +75.2% | +66.3% |
| Operating MarginEBIT ÷ Revenue | -29.5% | +7.8% | +8.4% | -27.2% | +30.5% |
| Net MarginNet income ÷ Revenue | -38.2% | +2.4% | +1.2% | -25.7% | +28.2% |
| FCF MarginFCF ÷ Revenue | -19.6% | +4.8% | +0.4% | -7.1% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -24.6% | +2.7% | -0.6% | +12.3% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -195.2% | -35.0% | +100.0% | -100.0% | +18.8% |
Valuation Metrics
SWK leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 30.3x trailing earnings, SWK trades at a 93% valuation discount to TTI's 439.9x P/E. On an enterprise value basis, SWK's 11.7x EV/EBITDA is more attractive than ISRG's 43.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2M | $12.5B | $1.3B | $1.9B | $161.1B |
| Enterprise ValueMkt cap + debt − cash | $95M | $18.0B | $1.5B | $2.1B | $158.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 30.26x | 439.86x | -13.80x | 57.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.64x | 41.38x | — | 43.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.65x |
| EV / EBITDAEnterprise value multiple | — | 11.71x | 15.93x | — | 43.62x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.82x | 2.09x | 2.92x | 16.00x |
| Price / BookPrice ÷ Book value/share | 0.03x | 1.35x | 4.67x | 5.51x | 9.17x |
| Price / FCFMarket cap ÷ FCF | — | 18.12x | 67.62x | — | 64.67x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-113 for IRBT. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRBT's 3.71x. On the Piotroski fundamental quality scale (0–9), SWK scores 6/9 vs IRBT's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -112.9% | +4.1% | +2.5% | -50.8% | +16.9% |
| ROA (TTM)Return on assets | -43.3% | +1.7% | +1.1% | -16.5% | +14.8% |
| ROICReturn on invested capital | -38.6% | +5.8% | +9.5% | -16.4% | +15.0% |
| ROCEReturn on capital employed | -27.7% | +7.0% | +9.7% | -28.9% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 3.71x | 0.65x | 0.93x | 0.85x | 0.02x |
| Net DebtTotal debt minus cash | $93M | $5.6B | $218M | $187M | -$3.1B |
| Cash & Equiv.Liquid assets | $134M | $280M | $45M | $103M | $3.4B |
| Total DebtShort + long-term debt | $227M | $5.9B | $263M | $290M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -3.36x | 2.07x | 2.96x | -96.80x | — |
Total Returns (Dividends Reinvested)
TTI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TTI five years ago would be worth $28,304 today (with dividends reinvested), compared to $6 for IRBT. Over the past 12 months, TTI leads with a +246.3% total return vs IRBT's -97.7%. The 3-year compound annual growth rate (CAGR) favors TTI at 48.9% vs IRBT's -88.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -55.0% | +5.9% | -0.3% | +28.3% | -19.3% |
| 1-Year ReturnPast 12 months | -97.7% | +41.7% | +246.3% | +1.1% | -15.4% |
| 3-Year ReturnCumulative with dividends | -99.9% | +6.9% | +229.9% | -75.7% | +49.6% |
| 5-Year ReturnCumulative with dividends | -99.9% | -56.2% | +183.0% | -91.3% | +58.7% |
| 10-Year ReturnCumulative with dividends | -99.9% | -1.5% | +96.4% | +30.3% | +554.2% |
| CAGR (3Y)Annualised 3-year return | -88.8% | +2.2% | +48.9% | -37.6% | +14.4% |
Risk & Volatility
Evenly matched — SWK and ISRG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than IRBT's 5.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SWK currently trades 85.9% from its 52-week high vs IRBT's 0.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 5.21x | 1.83x | 1.46x | 2.20x | 1.02x |
| 52-Week HighHighest price in past year | $6.10 | $93.37 | $12.54 | $20.06 | $603.88 |
| 52-Week LowLowest price in past year | $0.04 | $58.23 | $2.63 | $9.82 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +0.9% | +85.9% | +77.9% | +83.9% | +75.1% |
| RSI (14)Momentum oscillator 0–100 | 33.9 | 61.0 | 63.6 | 69.8 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 0 | 2.0M | 1.8M | 1.5M | 1.8M |
Analyst Outlook
SWK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SWK as "Hold", TTI as "Buy", NVCR as "Buy", ISRG as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs 11.2% for SWK (target: $89). SWK is the only dividend payer here at 4.10% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $89.17 | $12.25 | $33.50 | $622.60 |
| # AnalystsCovering analysts | — | 37 | 31 | 15 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | +4.1% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 16 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | $3.29 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | 0.0% | 0.0% | +1.4% |
ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SWK leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
IRBT vs SWK vs TTI vs NVCR vs ISRG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IRBT or SWK or TTI or NVCR or ISRG a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -23. 4% for iRobot Corporation (IRBT). Stanley Black & Decker, Inc. (SWK) offers the better valuation at 30. 3x trailing P/E (17. 6x forward), making it the more compelling value choice. Analysts rate TETRA Technologies, Inc. (TTI) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRBT or SWK or TTI or NVCR or ISRG?
On trailing P/E, Stanley Black & Decker, Inc.
(SWK) is the cheapest at 30. 3x versus TETRA Technologies, Inc. at 439. 9x. On forward P/E, Stanley Black & Decker, Inc. is actually cheaper at 17. 6x.
03Which is the better long-term investment — IRBT or SWK or TTI or NVCR or ISRG?
Over the past 5 years, TETRA Technologies, Inc.
(TTI) delivered a total return of +183. 0%, compared to -99. 9% for iRobot Corporation (IRBT). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus IRBT's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRBT or SWK or TTI or NVCR or ISRG?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus iRobot Corporation's 5. 21β — meaning IRBT is approximately 412% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 4% for iRobot Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — IRBT or SWK or TTI or NVCR or ISRG?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus -23. 4% for iRobot Corporation (IRBT). On earnings-per-share growth, the picture is similar: iRobot Corporation grew EPS 55. 3% year-over-year, compared to -97. 3% for TETRA Technologies, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRBT or SWK or TTI or NVCR or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -21. 3% for iRobot Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRBT or SWK or TTI or NVCR or ISRG more undervalued right now?
On forward earnings alone, Stanley Black & Decker, Inc.
(SWK) trades at 17. 6x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 26. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.
08Which pays a better dividend — IRBT or SWK or TTI or NVCR or ISRG?
In this comparison, SWK (4.
1% yield) pays a dividend. IRBT, TTI, NVCR, ISRG do not pay a meaningful dividend and should not be held primarily for income.
09Is IRBT or SWK or TTI or NVCR or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). iRobot Corporation (IRBT) carries a higher beta of 5. 21 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, IRBT: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRBT and SWK and TTI and NVCR and ISRG?
These companies operate in different sectors (IRBT (Consumer Cyclical) and SWK (Industrials) and TTI (Energy) and NVCR (Healthcare) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRBT is a small-cap quality compounder stock; SWK is a mid-cap income-oriented stock; TTI is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock. SWK pays a dividend while IRBT, TTI, NVCR, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.